Loss of cables, a novel gene on chromosome 18q, in ovarian cancer

被引:20
作者
Dong, Q
Kirley, S
Rueda, B
Zhao, C
Zukerberg, L
Oliva, E
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
关键词
cables; ovarian cancer; ovary; tumorigenesis;
D O I
10.1097/01.MP.0000084434.88269.0A
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cables, a cyclin-dependent kinase (cdk) interacting protein, has recently been identified and mapped to human chromosome 18q11. Cables appears to be primarily involved in cell cycle regulation and cell proliferation. Overexpression of Cables in Hela and other cell lines inhibits cell proliferation and tumor formation. We hypothesize that loss of Cables expression is associated with ovarian cancer. To test our hypothesis, we examined Cables expression in the four most common subtypes of ovarian carcinomas: serous, endometrioid, mucinous, and clear cell. In addition, mucinous and serous borderline tumors were also included. Loss of Cables expression was observed at high frequency in ovarian serous (I I of 14 cases, 79%) and endometrioid (5 of 10 cases, 50%) carcinomas. In contrast, strong Cables staining was detected in all clear cell carcinomas (10 cases) and mucinous tumors (5 carcinomas and 5 borderline tumors). The majority of serous borderline tumors (I I of 14 cases, 79%) showed positive Cables staining, with the rest showing focal loss of Cables expression. Furthermore, RT-PCR revealed the lack of Cables mRNA in a human ovarian cancer xenograft. No correlation was noted between loss of Cables and histologic grade, tumor stage, and survival. In conclusion, our results indicate that loss of Cables is common in ovarian serous and endometrioid carcinomas and imply that Cables may be involved in the pathogenesis of these two types of ovarian carcinomas.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 21 条
[1]  
Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO
[2]  
2-3
[3]   TUMOR-SUPPRESSOR GENES - OPEN QUESTIONS ON P16 [J].
BONETTA, L .
NATURE, 1994, 370 (6486) :180-180
[4]  
CLIBY W, 1993, CANCER RES, V53, P2393
[5]   Precursor lesions of ovarian epithelial malignancy [J].
Feeley, KM ;
Wells, M .
HISTOPATHOLOGY, 2001, 38 (02) :87-95
[6]   p53 and bcl-2 in epithelial ovarian carcinoma: Their value as prognostic indicators at a median follow-up of 60 months [J].
Geisler, JP ;
Geisler, HE ;
Miller, GA ;
Wiemann, MC ;
Zhou, Z ;
Crabtree, W .
GYNECOLOGIC ONCOLOGY, 2000, 77 (02) :278-282
[7]  
Gotley DC, 1996, ONCOGENE, V13, P787
[8]  
Hahn SA, 1996, CANCER RES, V56, P490
[9]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[10]   Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC [J].
Lassus, H ;
Salovaara, R ;
Aaltonen, LA ;
Butzow, R .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :35-42